drugset / Trial / NCT00485576
Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
RandomizedCrossoverQuadruple-blindPrevention
Summary
This study is to designed to test the role of complement in the late asthmatic response to allergen challenge in mild asthma, as an indicator of the possible role of complement in the broader asthmatic population.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-09
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eculizumab | Monoclonal antibody | 600 mg | Intravenous |